© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Multiple myeloma

Yolanda Brunson-Sarrabo
A Multiple Myeloma Diary
Yescarta, CAR-T, axicabtagene ciloleucel
New CAR-T for Multiple Myeloma
Multiple Myeloma 101

Multiple Myeloma Podcast

I’m teaming up with my buddy Kenny Capps for a cool podcast on everything thing myeloma.
Cancer treatment

Cancer Medications

New Drug Benefits Patients With Myeloma Who Are Resistant to All Therapies

Study focused on people who have exhausted available therapies but want to continue with treatment.
Yolanda Bunson-Sarrabo

What Fitness Gives Me

Yolanda Brunson-Sarrabo, CPT, NASM, is the author of “Another Face of Multiple Myeloma.”
Multiple myeloma cells

CAR-T Therapies for Multiple Myeloma Show High Response Rates

90% to 100% of study participants achieved complete or partial responses to treatment.

New Study Aims to Transform Myeloma Therapy Into Cure

A $4 million grant funds bench-to-bedside research to enhance immune-boosting power of autologous blood stem cell transplantation.
Chimeric antigen receptor T-cell (CAR-T) therapy

Failed Alzheimer’s Drug Might Boost CAR T-Cell Therapy for Multiple Myeloma

In a clinical trial, the research team is hoping to learn more about how myeloma cells resist CAR T-cell therapy.
Margot Pont, PhD

Failed Alzheimer’s Drug Boosts CAR T-Cell Therapy

Engineered immune cells get a helping hand in a new clinical trial for multiple myeloma patients.

FDA Approves Darzalex for Transplant-Eligible Multiple Myeloma

The approval is based on data from CASSIOPEIA, an open-label, randomized, active-controlled phase 3 study.

Blood Cancer Awareness Month

September was designated as National Blood Cancer Awareness Month in 2010 by United States Congress.

Darzalex

Bone Health

Even cancer that doesn’t affect the bones directly can contribute to bone problems.

ACA Leads to Better Care

The Affordable Care Act erases racial disparities in care for advanced cancers.

Study Finds Advantage for African Americans With Multiple Myeloma

“What was unique in this study was that in the VA, everybody is equal, and everyone gets the same access to drugs.”
Red and white blood cells

MGUS to Myeloma: Study Suggests Risk of Progression Can Change

Investigators say their findings support annual blood tests for all individuals with MGUS.
Multiple myeloma

Myeloma Awareness Month

In 2009, March was declared Myeloma Awareness Month (MAM).
Advertisement